Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recurrence × Gadolinium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 39 fludarabine 28 Dexamethasone 20 venetoclax 19 Cytarabine 16 Rituximab 13 pembrolizumab 12 fludarabine phosphate 12 Filgrastim 12 Gemcitabine 10 Etoposide 10 Granulocyte Colony-Stimulating Factor 9 carfilzomib 8 Vincristine 8 Topotecan 8 Interleukin-2 8 Decitabine 8 Nivolumab 7 Melphalan 7 Lenalidomide 7 Everolimus 7 Doxorubicin 7 Azacitidine 7 pomalidomide 6 Vorinostat 6 Carboplatin 6 Calcium Dobesilate 6 Bortezomib 6 obinutuzumab 5 ibrutinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03154996 2022-07-05

Chronic Convection Enhanced Delivery of Topotecan

Columbia University

Phase 1 Completed

Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡